Open AccessTreatment of Exudative Age-Related Macular Degeneration with Intravitreal Ranibizumab in Clinical Practice: A 3-Year Follow-Up
Author(s) -
Inês Marques,
Pedro Fonseca,
Maria Luz Cachulo,
Isabel Pires,
João Figueira,
J. R. Faria de Abreu,
Rufino Silva
Publication year - 2013
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000343709
Subject(s) - medicine , ranibizumab , macular degeneration , choroidal neovascularization , ophthalmology , visual acuity , fluorescein angiography , diabetic retinopathy , bevacizumab , surgery , diabetes mellitus , chemotherapy , endocrinology
To evaluate the 36-month efficacy of intravitreal ranibizumab injections for choroidal neovascularization secondary to age-related macular degeneration (AMD) in real world clinical practice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom